288 related articles for article (PubMed ID: 32329527)
21. Early add-on lacosamide in a real-life setting: results of the REALLY study.
Villanueva V; Garcés M; López-Gomáriz E; Serratosa JM; González-Giráldez B; Parra J; Rodríguez-Uranga J; Toledo M; López González FJ; Bermejo P; Giner P; Castillo A; Molins A; Campos D; Mauri JÁ; Muñoz R; Bonet M; Serrano-Castro P; del Villar A; Saiz-Díaz RA;
Clin Drug Investig; 2015 Feb; 35(2):121-31. PubMed ID: 25488477
[TBL] [Abstract][Full Text] [Related]
22. Management of epilepsy in brain tumor patients.
van der Meer PB; Taphoorn MJB; Koekkoek JAF
Curr Opin Oncol; 2022 Nov; 34(6):685-690. PubMed ID: 35838207
[TBL] [Abstract][Full Text] [Related]
23. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ
Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
[TBL] [Abstract][Full Text] [Related]
24. Lacosamide effectiveness and tolerability in patients with drug-resistant epilepsy and severe disability under polytherapy: Therapy optimization as emerging from an observational study.
Pozzi M; Zanotta N; Epifanio R; Baldelli S; Cattaneo D; Clementi E; Zucca C
Epilepsy Behav; 2022 Mar; 128():108598. PubMed ID: 35151192
[TBL] [Abstract][Full Text] [Related]
25. Perampanel and lacosamide monotherapy in pediatric patients with newly diagnosed focal epilepsy: A prospective study evaluating efficacy, tolerability, and behavior.
Zhou R; Qu R; Liu M; Huang DP; Zhou JY; Chen Y; Chen XQ
Epilepsy Behav; 2023 Sep; 146():109353. PubMed ID: 37481960
[TBL] [Abstract][Full Text] [Related]
26. [Russian experience of lacosamide (vimpat) usage in treatment of uncontrolled focal epilepsy].
Lebedeva AV; Burd SG; Belyaev OV; Vlasov PN; Dorofeeva MY; Ismailov AM; Kissin MY; Kovaleva IY; Koroleva NY; Lipatova LV; Mukhin KY; Solomatin YV; Chervyakov AV; Shikhkerimov RG; Pylaeva OA; Freidkova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9. Vyp. 2):74-81. PubMed ID: 28005051
[TBL] [Abstract][Full Text] [Related]
27. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.
Steinhoff BJ; Eckhardt K; Doty P; De Backer M; Brunnert M; Schulze-Bonhage A
Epilepsy Behav; 2016 May; 58():35-43. PubMed ID: 27054272
[TBL] [Abstract][Full Text] [Related]
28. Lacosamide in patients with epilepsy of cerebrovascular etiology.
Rosenow F; Brandt C; Bozorg A; Dimova S; Steiniger-Brach B; Zhang Y; Ferrò B; Holmes GL; Kälviäinen R
Acta Neurol Scand; 2020 Jun; 141(6):473-482. PubMed ID: 32068241
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
[TBL] [Abstract][Full Text] [Related]
31. Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial.
Farkas MK; Beller C; Bozorg A; McClung C; Roebling R; Yates T; Yuen N; Makedonska I
Epilepsia Open; 2023 Mar; 8(1):146-153. PubMed ID: 36529709
[TBL] [Abstract][Full Text] [Related]
32. Tolerability and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy and concomitant psychiatric conditions: Post hoc analysis of a prospective, randomized, double-blind trial.
Schmitz B; Dimova S; Zhang Y; Chellun D; De Backer M; Gasalla T
Epilepsy Res; 2020 Jan; 159():106220. PubMed ID: 31812127
[TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
34. Perampanel in brain tumor-related epilepsy: Observational pilot study.
Maschio M; Zarabla A; Maialetti A; Giannarelli D; Koudriavtseva T; Villani V; Zannino S
Brain Behav; 2020 Jun; 10(6):e01612. PubMed ID: 32285623
[TBL] [Abstract][Full Text] [Related]
35. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON).
Abril Jaramillo J; Estévez María JC; Girón Úbeda JM; Vega López Ó; Calzado Rivas ME; Pérez Díaz H; García Martín G; Vila Herrero E; Chamorro-Muñoz M; Vázquez F; De la Fuente C; Redondo L; Peláez N; Santágueda P; Rodríguez Uranga JJ
Epilepsy Behav; 2020 Jan; 102():106655. PubMed ID: 31812902
[TBL] [Abstract][Full Text] [Related]
37. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
[TBL] [Abstract][Full Text] [Related]
38. Lacosamide monotherapy in clinical practice: A retrospective chart review.
Villanueva V; Giráldez BG; Toledo M; De Haan GJ; Cumbo E; Gambardella A; De Backer M; Joeres L; Brunnert M; Dedeken P; Serratosa J
Acta Neurol Scand; 2018 Sep; 138(3):186-194. PubMed ID: 29542107
[TBL] [Abstract][Full Text] [Related]
39. Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice.
Reinhardt F; Weber YG; Mayer T; Luef G; Joeres L; Tennigkeit F; Dedeken P; De Backer M; Hellot S; Lauterbach T; Webers T; Arnold S
Epilepsia Open; 2019 Sep; 4(3):409-419. PubMed ID: 31440722
[TBL] [Abstract][Full Text] [Related]
40. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
